- Home
- MDB vs A Comparison
MDB vs A Comparison
Compare MDB & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDB | A |
|---|---|---|
| Founded | 2007 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.8B | 39.8B |
| IPO Year | 2017 | 1999 |
Fundamental Metrics
Financial Performance| Metric | MDB | A |
|---|---|---|
| Price | $429.55 | $136.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 37 | 15 |
| Target Price | ★ $413.25 | $162.80 |
| AVG Volume (30 Days) | ★ 2.3M | 2.3M |
| Earning Date | 12-01-2025 | 11-24-2025 |
| Dividend Yield | N/A | ★ 0.75% |
| EPS Growth | N/A | ★ 3.16 |
| EPS | N/A | ★ 4.57 |
| Revenue | $2,317,123,000.00 | ★ $6,948,000,000.00 |
| Revenue This Year | $18.77 | $7.76 |
| Revenue Next Year | $17.04 | $6.24 |
| P/E Ratio | ★ N/A | $29.96 |
| Revenue Growth | ★ 20.93 | 6.73 |
| 52 Week Low | $140.78 | $96.43 |
| 52 Week High | $432.55 | $160.27 |
Technical Indicators
Market Signals| Indicator | MDB | A |
|---|---|---|
| Relative Strength Index (RSI) | 68.19 | 35.40 |
| Support Level | $408.00 | $136.23 |
| Resistance Level | $432.55 | $143.37 |
| Average True Range (ATR) | 13.76 | 3.01 |
| MACD | 1.69 | -1.29 |
| Stochastic Oscillator | 90.83 | 2.63 |
Price Performance
Historical ComparisonAbout MDB MongoDB Inc.
Founded in 2007, MongoDB is a vendor of a document-oriented database that accelerates development processes of new applications. Enterprise customers can choose between the fully managed offering, MongoDB Atlas, or the self-managed version, MongoDB Enterprise Advanced. MongoDB is a popular tool among developers, and its free Community Server has recorded over 500 million downloads since 2009.
About A Agilent Technologies Inc.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.